NASDAQ:HROW

Imprimis Pharmaceuticals Stock Predictions

Healthcare > Drug Manufacturers - Specialty & Generic

Buy HROW

*Your capital is at risk

$33.32

+0.460 (+1.40%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

HROW Prediction Chart

HROW Predictions History

Latest community submissions for HROW.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Dec 28, 2016	$2.70 +10.66%	$2.44	X	89.30%	0
Christopher.Michael.Perdigao.1751	Dec 28, 2016	$3.00 +22.95%	$2.44	X	77.00%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HROW with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT IMPRIMIS PHARMACEUTICALS

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharma...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by